Plasma B-type natriuretic peptide as a marker of myocardial asynchrony

Katarzyna Ciuraszkiewicz1, Marianna Janion, Dariusz Dudek

  • 1Swietokrzyskie Centrum Kardiologii, Akademia Swietokrzyska, Kielce, Poland.

Cardiology
|January 20, 2009
PubMed

Insights

Plasma B-type natriuretic peptide (BNP) levels in heart attack patients with intraventricular conduction defects (IVCD) are influenced by left ventricular (LV) asynchrony, especially with preserved LV systolic function.

Area of Science:

  • Cardiology
  • Biomarkers
  • Echocardiography

Background:

  • Myocardial infarction (MI) can lead to intraventricular conduction defects (IVCD).
  • Myocardial asynchrony is a potential complication in post-MI patients with IVCD.
  • B-type natriuretic peptide (BNP) is a biomarker used in heart failure assessment.

Purpose of the Study:

  • To evaluate asynchrony parameters in post-MI patients with IVCD.
  • To define the relationship between plasma BNP levels and echocardiographic measures of asynchrony.

Main Methods:

  • 158 patients 6 months post-MI were studied (126 with IVCD, 32 without).
  • Plasma BNP levels were measured using an immunoenzymatic method.
  • Left ventricular (LV) function and asynchrony were assessed via echocardiography.

Main Results:

  • Patients with post-MI IVCD exhibited significantly higher interventricular asynchrony and BNP levels compared to those without IVCD.
  • In patients with preserved LV ejection fraction (EF) > or =50%, interventricular asynchrony and intraventricular delay significantly impacted BNP levels.
  • In patients with reduced LV EF <50%, BNP levels correlated with the magnitude of EF.

Conclusions:

  • Plasma BNP levels 6 months post-MI are influenced by LV asynchrony in addition to LV function.
  • BNP may serve as a marker of LV asynchrony in post-MI patients with IVCD and preserved LV systolic function.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...